GUARDANT HEALTH, INC. Expense Breakdown
No Expense Breakdown for GH on this site yet.
- 2026-06-30: Reportable $111.85M.
- 2025-06-30: Reportable $78.30M.
Source checked: the stored Expense Breakdown page for GH.
Expenses by product
Cost of sales: each quarter (3 month)
| Quarter end | Reportable |
|---|---|
| 2026-06-30 | $111.85M |
| 2025-06-30 | $78.30M |
Research And Development Expense Adjusted: each quarter (3 month)
| Quarter end | Reportable |
|---|---|
| 2026-06-30 | $80.51M |
| 2025-06-30 | $72.55M |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| LABCORP HOLDINGS INC. (LH) | United States | $25.060B | 22.60 |
| QUEST DIAGNOSTICS INC (DGX) | United States | $26.096B | 22.09 |
| Caris Life Sciences, Inc. (CAI) | United States | $9.119B | 47.87 |
| RadNet, Inc. (RDNT) | United States | $5.611B | -229.65 |
| GRAIL, Inc. (GRAL) | United States | $5.591B | -7.78 |
| VERACYTE, INC. (VCYT) | United States | $3.904B | 41.21 |
| Celcuity Inc. (CELC) | United States | $3.887B | -22.62 |
| CareDx, Inc. (CDNA) | United States | $3.174B | 13.21 |
| Fortrea Holdings Inc. (FTRE) | United States | $1.903B | -19.43 |
| Personalis, Inc. (PSNL) | United States | $1.769B | -13.30 |